Multimodal EPs predict no evidence of disease activity at two years of first line multiple sclerosis treatment

Authors
Category Primary study
JournalNeurology
Year 2017
This article has no abstract
Epistemonikos ID: a08635e564e900eddc5b0d06a7d5d3cad697aa6d
First added on: Feb 08, 2025